Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.
Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable safety and evidence of anti-leukemic activity with an ...
Current research in the Doudna lab focuses on discovering and determining the mechanisms of novel CRISPR-Cas and associated proteins; developing genome editing tools for use in vitro, in plants, and ...
The future of medicine is being shaped by a confluence of factors at play. If there are worries galore around drug resistant ...
The Times of Israel on MSN3d
Israeli researchers use gene editing to eliminate 50% of head, neck tumors in miceTel Aviv University scientists say that they can inject CRISPR genetic 'molecular scissors' to shrink tumors by 90%; ...
Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different ...
Momentum Builds Across Programs with Key Data Milestones Expected in 2025Cemacabtagene Ansegedleucel (Cema-Cel): First-Line (1L) Consolidation in ...
SciFiNow on MSN3d
“We had just one rule – nothing is sacred…” Stu Jones and Gareth Worthington on OmniviolenceFrom authors Stu Jones and Gareth Worthington (under the combined pseudonym Jones Worthington) new sci-fi action novel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback